Cardiac dysfunction in mixed connective tissue disease: a nationwide observational study.


Journal

Rheumatology international
ISSN: 1437-160X
Titre abrégé: Rheumatol Int
Pays: Germany
ID NLM: 8206885

Informations de publication

Date de publication:
06 2023
Historique:
received: 09 12 2022
accepted: 06 03 2023
medline: 26 4 2023
pubmed: 19 3 2023
entrez: 18 3 2023
Statut: ppublish

Résumé

We aimed to identify cardiac function in patients with established mixed connective tissue disease (MCTD). This was a cross-sectional case-control study of well-characterised MCTD patients who had previously been included in a nationwide cohort. Assessments comprised protocol transthoracic echocardiography, electrocardiogram and blood samples. In patients only, we evaluated the findings of high-resolution pulmonary computed tomography and disease activity. We assessed 77 MCTD patients (mean age 50.5 ± 12.3 years) with a mean disease duration of 16.4 years, and 59 age- and sex-matched healthy controls (49.9 ± 11.7 years). By echocardiography, measures of left ventricular function, i.e. fractional shortening (38.1 ± 6.4% vs. 42.3 ± 6.6%, p < 0.001), mitral annulus plane systolic excursion (MAPSE) (13.7 ± 2.1 mm vs. 15.3 ± 2.3 mm, p < 0.001) and early diastolic velocity of the mitral annulus (e') (0.09 ± 0.02 m/s vs. 0.11 ± 0.03 m/s, p = 0.002) were subclinical and lower in patients than controls. Right ventricular dysfunction was found in patients assessed by tricuspid annular plane systolic excursion (TAPSE) (22.7 ± 4.0 mm vs. 25.5 ± 4.0 mm, p < 0.001). While cardiac dysfunction was not associated with pulmonary disease, e' and TAPSE were found to correlate with disease activity at baseline. In this cohort of MCTD patients, echocardiographic examinations demonstrated a higher frequency of cardiac dysfunction than in matched controls. Cardiac dysfunction was associated with disease activity at baseline, but was independent of cardiovascular risk factors and pulmonary disease. Our study indicates that cardiac dysfunction is part of the multi-organ affliction seen in MCTD.

Identifiants

pubmed: 36933069
doi: 10.1007/s00296-023-05308-3
pii: 10.1007/s00296-023-05308-3
pmc: PMC10126085
doi:

Types de publication

Observational Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1055-1065

Informations de copyright

© 2023. The Author(s).

Références

Heart. 1997 Sep;78(3):230-6
pubmed: 9391283
N Engl J Med. 1976 Nov 18;295(21):1149-54
pubmed: 1086429
Ann Rheum Dis. 2011 Jun;70(6):1047-51
pubmed: 21398332
Arthritis Rheum. 1999 May;42(5):899-909
pubmed: 10323445
Circulation. 1983 Dec;68(6):1182-93
pubmed: 6640871
Eur Heart J Cardiovasc Imaging. 2015 Mar;16(3):233-70
pubmed: 25712077
Best Pract Res Clin Rheumatol. 2016 Feb;30(1):95-111
pubmed: 27421219
Int J Cardiol. 2014 Feb 15;171(3):326-30
pubmed: 24433611
Chest. 1983 Feb;83(2):185-8
pubmed: 6822098
Chest. 2005 Sep;128(3):1836-52
pubmed: 16162794
J Rheumatol. 2019 Jul;46(7):739-747
pubmed: 30877222
Semin Arthritis Rheum. 1986 May;15(4):288-96
pubmed: 2940685
Am Heart J. 1949 Feb;37(2):161-86
pubmed: 18107386
J Am Coll Cardiol. 2018 Nov 6;72(19):2360-2379
pubmed: 30384893
Eur Heart J. 2021 Dec 21;42(48):4901
pubmed: 34649282
Best Pract Res Clin Rheumatol. 2012 Feb;26(1):61-72
pubmed: 22424193
Reumatologia. 2016;54(4):187-195
pubmed: 27826173
Ann Rheum Dis. 2017 Jan;76(1):270-276
pubmed: 27621285
Clin Rheumatol. 2007 Feb;26(2):176-81
pubmed: 16865311
Rheumatology (Oxford). 2018 Feb 1;57(2):255-262
pubmed: 28379478
J Rheumatol. 2013 Jul;40(7):1134-42
pubmed: 23637328
Cardiology. 1990;77(2):93-100
pubmed: 2397491
Rheumatology (Oxford). 2015 Mar;54(3):528-35
pubmed: 25187641
J Rheumatol. 2002 Feb;29(2):288-91
pubmed: 11838846
Am J Med. 1972 Feb;52(2):148-59
pubmed: 4621694
J Autoimmun. 2014 Feb-Mar;48-49:46-9
pubmed: 24461387
Eur Heart J Cardiovasc Imaging. 2013 Mar;14(3):205-12
pubmed: 23161791
Open Heart. 2016 May 09;3(1):e000408
pubmed: 27175288
Immunol Rev. 2010 Jan;233(1):126-45
pubmed: 20192997
Eur Heart J. 2019 Oct 21;40(40):3297-3317
pubmed: 31504452

Auteurs

Simon Girmai Berger (SG)

Institute for Experimental Medical Research, K. G. Jebsen Center for Cardiac Research, Oslo University Hospital Ullevål, University of Oslo, PB 4956 Nydalen, 0424, Oslo, Norway.
Department of Acute Medicine, Oslo University Hospital, Oslo, Norway.

Birgit Nomeland Witczak (BN)

Institute for Experimental Medical Research, K. G. Jebsen Center for Cardiac Research, Oslo University Hospital Ullevål, University of Oslo, PB 4956 Nydalen, 0424, Oslo, Norway.

Silje Reiseter (S)

Martina Hansens Hospital, Sandvika, Norway.

Thomas Schwartz (T)

Oslo New University College, Oslo, Norway.
Department of Medicine, Diakonhjemmet Hospital, Oslo, Norway.

Helena Andersson (H)

Department of Rheumatology, Oslo University Hospital, Oslo, Norway.

Siri Opsahl Hetlevik (SO)

Department of Rheumatology, Oslo University Hospital, Oslo, Norway.

Kristin Schjander Berntsen (KS)

Department of Rheumatology, Oslo University Hospital, Oslo, Norway.

Helga Sanner (H)

Department of Rheumatology, Oslo University Hospital, Oslo, Norway.
Oslo New University College, Oslo, Norway.

Vibke Lilleby (V)

Department of Rheumatology, Oslo University Hospital, Oslo, Norway.

Ragnar Gunnarsson (R)

Department of Rheumatology, Oslo University Hospital, Oslo, Norway.

Øyvind Molberg (Ø)

Department of Rheumatology, Oslo University Hospital, Oslo, Norway.
Institute for Clinical Medicine, Medical Faculty, University of Oslo, Oslo, Norway.

Ivar Sjaastad (I)

Institute for Experimental Medical Research, K. G. Jebsen Center for Cardiac Research, Oslo University Hospital Ullevål, University of Oslo, PB 4956 Nydalen, 0424, Oslo, Norway.
Department of Cardiology, Oslo University Hospital Ullevål, Oslo, Norway.

Mathis Korseberg Stokke (MK)

Institute for Experimental Medical Research, K. G. Jebsen Center for Cardiac Research, Oslo University Hospital Ullevål, University of Oslo, PB 4956 Nydalen, 0424, Oslo, Norway. m.k.stokke@medisin.uio.no.
Department of Cardiology, Oslo University Hospital Rikshospitalet, Oslo, Norway. m.k.stokke@medisin.uio.no.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH